Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Botulinum toxin E - Ipsen

Next Previous
Search
Drug Profile

Botulinum toxin E - Ipsen

Alternative Names: IPN 10360; modified recombinant Botulinum NeuroToxin/E; mrBoNT/E; rBoNT-E; rBoNT/E - Ipsen

Latest Information Update: 04 Aug 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ipsen
  • Class Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants; Recombinant proteins; Skin disorder therapies
  • Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Glabellar lines

Most Recent Events

  • 30 Jun 2020 Discontinued - Phase-I for Glabellar lines (In volunteers) in France (Parenteral) before June 2020
  • 28 May 2020 No recent reports of development identified for phase-I development in Glabellar-lines(In volunteers) in France (Parenteral)
  • 26 Feb 2020 Ipsen plans a phase II trial for Glabellar lines in 2020

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top